Open-source liquid handling robots for research and biopharma labs
Opentrons makes programmable lab automation systems built on Python and TypeScript, deployed across thousands of research institutions globally. The tech stack (Python-heavy, React frontend, Electron for desktop control) and active projects—AI-powered protocol generation, system upgrades, next-gen robot design—reveal an engineering org scaling toward software-driven automation. Pain points cluster around reliability, manufacturing yield, and installed-base maintenance, indicating a maturing hardware business now tackling operational and quality scaling.
Opentrons Labworks operates two business units: Opentrons Robotics, which builds and distributes liquid handling automation platforms, and Neochromosome, focused on genome-scale cell engineering. The Robotics platform—featuring open-source software and hardware—is installed in academic, biopharma, synthetic biology, and clinical research labs across 40+ countries. The company sells into both high-volume research institutions and regulated biotech/pharma environments. With 201–500 employees based in Long Island City, NY, and hiring distributed across engineering, sales, finance, support, and logistics, the organization is actively managing deployment, maintenance, and product development at scale.
Python, TypeScript, React, HTML, CSS, UPS, NetSuite, and SuiteScript. Python and TypeScript dominate the core platform; React and Electron power the desktop control interface.
Opentrons platforms are installed in thousands of academic, biopharma, synthetic biology, and clinical research labs across more than 40 countries, with the largest deployment concentration in institutional research settings.
Other companies in the same industry, closest in size